These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24442582)

  • 41. A single-chain TALEN architecture for genome engineering.
    Sun N; Zhao H
    Mol Biosyst; 2014 Mar; 10(3):446-53. PubMed ID: 24336919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of TALEN scaffolds in Xenopus tropicalis.
    Nakajima K; Yaoita Y
    Biol Open; 2013 Dec; 2(12):1364-70. PubMed ID: 24285709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease.
    Sun N; Liang J; Abil Z; Zhao H
    Mol Biosyst; 2012 Apr; 8(4):1255-63. PubMed ID: 22301904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Overview of TALEN Construction Systems.
    Sakuma T; Yamamoto T
    Methods Mol Biol; 2017; 1630():25-36. PubMed ID: 28643246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A TALE of two nucleases: gene targeting for the masses?
    Clark KJ; Voytas DF; Ekker SC
    Zebrafish; 2011 Sep; 8(3):147-9. PubMed ID: 21929364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds.
    Rhiel M; Geiger K; Andrieux G; Rositzka J; Boerries M; Cathomen T; Cornu TI
    Front Genome Ed; 2023; 5():1130736. PubMed ID: 36890979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Highly efficient targeted mutagenesis in mice using TALENs.
    Panda SK; Wefers B; Ortiz O; Floss T; Schmid B; Haass C; Wurst W; Kühn R
    Genetics; 2013 Nov; 195(3):703-13. PubMed ID: 23979585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An efficient TALEN mutagenesis system in rice.
    Chen K; Shan Q; Gao C
    Methods; 2014 Aug; 69(1):2-8. PubMed ID: 24556552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TALEN-Mediated Mutagenesis and Genome Editing.
    Ma AC; Chen Y; Blackburn PR; Ekker SC
    Methods Mol Biol; 2016; 1451():17-30. PubMed ID: 27464798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient TALEN construction and evaluation methods for human cell and animal applications.
    Sakuma T; Hosoi S; Woltjen K; Suzuki K; Kashiwagi K; Wada H; Ochiai H; Miyamoto T; Kawai N; Sasakura Y; Matsuura S; Okada Y; Kawahara A; Hayashi S; Yamamoto T
    Genes Cells; 2013 Apr; 18(4):315-26. PubMed ID: 23388034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detailed analysis of targeted gene mutations caused by the Platinum-Fungal TALENs in Aspergillus oryzae RIB40 strain and a ligD disruptant.
    Mizutani O; Arazoe T; Toshida K; Hayashi R; Ohsato S; Sakuma T; Yamamoto T; Kuwata S; Yamada O
    J Biosci Bioeng; 2017 Mar; 123(3):287-293. PubMed ID: 27780671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TALEN gene editing takes aim on HIV.
    Benjamin R; Berges BK; Solis-Leal A; Igbinedion O; Strong CL; Schiller MR
    Hum Genet; 2016 Sep; 135(9):1059-70. PubMed ID: 27170155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A robust TALENs system for highly efficient mammalian genome editing.
    Feng Y; Zhang S; Huang X
    Sci Rep; 2014 Jan; 4():3632. PubMed ID: 24407151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methods for targeted mutagenesis in zebrafish using TALENs.
    Hwang WY; Peterson RT; Yeh JR
    Methods; 2014 Aug; 69(1):76-84. PubMed ID: 24747922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering.
    Liu J; Gaj T; Patterson JT; Sirk SJ; Barbas CF
    PLoS One; 2014; 9(1):e85755. PubMed ID: 24465685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.
    Holkers M; Maggio I; Liu J; Janssen JM; Miselli F; Mussolino C; Recchia A; Cathomen T; Gonçalves MA
    Nucleic Acids Res; 2013 Mar; 41(5):e63. PubMed ID: 23275534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The I-TevI nuclease and linker domains contribute to the specificity of monomeric TALENs.
    Kleinstiver BP; Wang L; Wolfs JM; Kolaczyk T; McDowell B; Wang X; Schild-Poulter C; Bogdanove AJ; Edgell DR
    G3 (Bethesda); 2014 Apr; 4(6):1155-65. PubMed ID: 24739648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An optimized TALEN application for mutagenesis and screening in
    Lee HB; Sebo ZL; Peng Y; Guo Y
    Cell Logist; 2015; 5(1):e1023423. PubMed ID: 26196022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TAL effector nuclease (TALEN) engineering.
    Li T; Yang B
    Methods Mol Biol; 2013; 978():63-72. PubMed ID: 23423889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.